Physician profile
David E Krummen
NPI 1235152885
$5,914.41
in general payments reported to CMS, 2019-2025
15 companies · $2,201 in 2025
The $2,201 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $231 · 2021: $25.00 · 2022: $400 · 2023: $1,204 · 2024: $914 · 2025: $2,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,370 · Travel and Lodging: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,370.34 |
| Travel and Lodging | $949.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,699.97 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Impulse Dynamics (USA) INC. | $755.99 | 2022-2024 | Optimizer, Optimizer |
| Medtronic, INC. | $631.58 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $499.38 | 2019-2025 | Amvia Edge |
| Kestra Medical Technology Services, INC. | $382.36 | 2023-2025 | Assure Wcd |
| Stryker Corporation | $223.86 | 2019-2025 | N/A |
| Medtronic Vascular, INC. | $220.95 | 2019-2020 | |
| Cardiva Medical, INC. | $130.14 | 2019 | |
| Philips North America LLC | $121.63 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Boston Scientific Corporation | $88.28 | 2019-2024 | |
| Biosense Webster, INC. | $66.70 | 2023-2025 | Carto 3 |
| Atricure, INC. | $54.67 | 2025 | Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.58 | 2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $15.32 | 2024 | Farxiga |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$21,581,767.76 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Krummen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.